A7023258
Dasatinib(monohydrate) , 10mMinDMSO , 863127-77-9
CAS NO.：863127-77-9
Empirical Formula: C22H28ClN7O3S
Molecular Weight: 506.02
MDL number: MFCD08704581
EINECS: 638-874-6
| Pack Size | Price | Stock | Quantity |
| 1ml | RMB159.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | >223° (dec.) |
| storage temp. | Keep in dark place,Sealed in dry,Store in freezer, under -20°C |
| solubility | DMSO (Slightly, Sonicated), Methanol (Slightly, Sonicated) |
| form | Solid |
| color | White to Off-White |
| Stability: | Hygroscopic |
| InChIKey | XHXFZZNHDVTMLI-UHFFFAOYSA-N |
| SMILES | N(C1=NC=C(C(=O)NC2C(=CC=CC=2C)Cl)S1)C1N=C(C)N=C(N2CCN(CCO)CC2)C=1.O |
| CAS DataBase Reference | 863127-77-9(CAS DataBase Reference) |
Description and Uses
Dasatinib monohydrate is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity.
Dasatinib Monohydrate is an orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. It is a COVID19-related research product. It is used in the treatment of patients with chronic myeloid leukemia who are resistant or intolerant to imatinib.
Safety
| Symbol(GHS) |    GHS08,GHS09,GHS06 |
| Signal word | Danger |
| Hazard statements | H410-H300-H372-H361-H360 |
| Precautionary statements | P264-P270-P301+P310-P321-P330-P405-P501-P260-P264-P270-P314-P501-P273-P391-P501-P201-P202-P281-P308+P313-P405-P501 |
| HS Code | 29339900 |
